[Form 4] American Integrity Insurance Group, Inc. Insider Trading Activity
American Integrity Insurance Group, Inc. (AII) director Ernest N. Csiszar was granted 886 shares of restricted common stock on 09/09/2025 as director compensation under the companys 2025 Long-Term Incentive Plan. The report shows the shares were issued at no cash price ($0) and that the reporting person beneficially owned 886 shares following the transaction. The restricted shares are subject to a 180-day lock-up under the reporting person's lock-up agreement entered into in connection with the issuers initial public offering. The Form 4 was signed by the reporting person on 09/10/2025.
- Director compensation granted in equity (886 restricted shares), which aligns the reporting persons interests with shareholders
- Shares subject to IPO lock-up, indicating restriction on immediate sale consistent with underwriting agreements
- None.
Insights
TL;DR: Director received 886 restricted shares as compensation, aligning pay with shareholder value; transaction appears routine and non-dilutive.
The Form 4 discloses a non-derivative grant of 886 restricted common shares to a director on 09/09/2025 under the 2025 Long-Term Incentive Plan. The shares were issued at $0 and the reporting person holds 886 shares after the grant. The filing notes a 180-day lock-up tied to the IPO underwriter agreement, which limits immediate transferability. This is a typical director equity award following an IPO and has limited direct impact on outstanding share count disclosed here; it signals standard alignment of management incentives with shareholders.
TL;DR: Routine director equity grant with standard IPO lock-up; governance signal is alignment but not a material governance change.
The disclosure documents a director compensation action: 886 restricted shares granted as director compensation and subject to a 180-day lock-up tied to the underwriter agreement. The Form 4 indicates direct beneficial ownership and an immediate post-grant holding of 886 shares. From a governance perspective, the transaction follows common post-IPO practices to retain directors and align incentives. The filing does not indicate accelerated vesting, extraordinary terms, or related-party conflicts.